Philip Drew
9Patents
4h-index
12Co-inventors
46Inventor score
Filing activity: Apr 20, 2012 → Dec 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9475879B2 | Antibody polypeptides that antagonize CD40 | Chemistry; Metallurgy | 21 | Active |
| US8895010B2 | Antibody polypeptides that antagonize CD40L | Chemistry; Metallurgy | 18 | Active |
| US9228018B2 | Antibody polypeptides that antagonize CD40L | Chemistry; Metallurgy | 10 | Active |
| US8981072B2 | Nucleic acids encoding antibody polypeptides that antagonize CD40L | Chemistry; Metallurgy | 8 | Active |
| US10544228B2 | Nucleic acids encoding antibody polypeptides that antagonize CD40 | Chemistry; Metallurgy | 1 | Active |
| US9765150B2 | Antibody polypeptides that antagonize CD40L | Chemistry; Metallurgy | 1 | Active |
| US10196451B2 | Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L | Chemistry; Metallurgy | 1 | Active |
| US11136406B2 | Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40 | Chemistry; Metallurgy | 0 | Active |
| US11180567B2 | Antibody polypeptides that antagonize CD40L | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.